Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Czucman MS"'
Autor:
Cheah CY; Department of Haematology, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Melbourne, VIC, Australia; Department of Lymphoma and Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Belada D; Fourth Department of Internal Medicine-Hematology, University Hospital and Faculty of Medicine, Hradec Kralove, Czech Republic., Fanale MA; Department of Lymphoma and Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Janikova A; Department of Hematology and Oncology, University Hospital Brno, Brno, Czech Republic; Masaryk University Faculty of Medicine Brno, Brno, Czech Republic., Czucman MS; Roswell Park Cancer Institute, Buffalo Park, NY, USA., Flinn IW; Sarah Cannon Research Institute, Tennessee Oncology, Nashville, TN, USA., Kapp AV; Genentech, South San Francisco, CA, USA., Ashkenazi A; Genentech, South San Francisco, CA, USA., Kelley S; Genentech, South San Francisco, CA, USA., Bray GL; Genentech, South San Francisco, CA, USA., Holden S; Genentech, South San Francisco, CA, USA., Seymour JF; Department of Haematology, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Melbourne, VIC, Australia. Electronic address: john.seymour@petermac.org.
Publikováno v:
The Lancet. Haematology [Lancet Haematol] 2015 Apr; Vol. 2 (4), pp. e166-74. Date of Electronic Publication: 2015 Mar 25.